No profile data available.
Iradimed Corporation (IRMD) is a healthcare company in the IV treatment equipment industry, based in Orlando, United States, with about 166 full-time employees.
It reported revenue of $83.81 million for fiscal year 2025, up 14.4% from fiscal year 2024, and net income of $22.48 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $20.47 million, up 0.3% from a year before. United States was its largest region in fiscal year 2025, with 84% of revenue. Its market capitalization was $1.12 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories.
Iradimed reported $83.81 million in revenue for fiscal year 2025, up 14.4% from $73.24 million in fiscal year 2024. In Q2 2026 revenue was $20.47 million.
United States: 84% of revenue by region in fiscal year 2025, followed by International (16%).
$1.12 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (IV treatment equipment) include Insulet Corporation (PODD), ICU Medical, Inc. (ICUI), Tandem Diabetes Care, Inc. (TNDM), Beta Bionics, Inc. (BBNX).